Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 Apr 2023
In the second week of life, 83 percent of newborns who were fed formula milk had Clostridium difficile and Clostridium perfringens, but by the end of the third week, all infants had these infections.
Read Full NewsHCPLive previews GOLD 2026 in Philadelphia, November 5-6, with sessions on the 2027 GOLD Report, mucus plugging, and exacerbations, plus expert interviews.
7 Pulmonology Headlines You Missed in October
Nasal mRNA ETH47 Lowers Rhinovirus Load in Asthma Challenge Study
Q&A: Why 70% of COPD Goes Undiagnosed, With Alvar Agustí, MD
Mucus Plugs in COPD: Prevalence, Exacerbations, Mortality Risk
Richard Nowak, MD, director of the Yale Myasthenia Gravis Clinic and global principal investigator of the MINT trial, discusses open-label extension findings for inebilizumab, a CD19-directed B cell depleting therapy, in generalized myasthenia gravis.
uniQure presented final safety and biomarker results from the discontinued EPISOD1 trial of AMT-162, an investigational gene therapy for SOD1-associated ALS.
1.
What's Behind the Mysterious Chest Pain in Bladder Cancer Patient?
2.
Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?
3.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
4.
Citing a cancer risk, the EPA sets a new limit on medical sterilization chemicals.
5.
In cases of locally advanced, potentially curable pancreatic cancer, a combination of drugs enhances the results of radiation therapy.
1.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
2.
CA-125 Test: Why It's Important for Women's Health and Early Detection of Ovarian Cancer
3.
Integrated Models in Hematology for Specialists
4.
Engineered Hematopoietic Cells for Targeted Correction of Abnormal Blood-Cell Production
5.
The Impact of Microadenoma on Hormonal Health
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
2.
Recognizing Symptoms That May Require Cancer Evaluation
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
4.
Updates on the First Line Management of ALK+ NSCLC
5.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge